FlowReserve develops innovative technology based on artificial intelligence for the early prevention of diseases, especially cardiovascular diseases. FlowReserve seeks to be recognized for its ability to improve people’s quality of life, reduce the costs associated with the treatment of cardiovascular diseases and contribute to the sustainability of the global healthcare system. To achieve this, FlowReserve focuses on the research and ongoing development of technologies that enable more accurate, faster, safer and non-invasive diagnosis of cardiovascular diseases, which can be used by healthcare professionals worldwide.